A new study led by scientists from the University of Zurich and the University Hospital of Psychiatry Zurich has found a ...

The retina, as part of the central nervous system, may reflect early signs of brain disorders like schizophrenia.

On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is ...

The retina is part of the central nervous system, and therefore a direct extension of the brain. This is why changes in the ...

Bristol Myers Squibb's Cobenfy as an adjunctive treatment did not reach the threshold for a statistically significant difference compared to a placebo with an atypical antipsychotic in adults with ...

A new study has identified the protein hnRNP A1 as a key player in the production and maintenance of myelin, the fatty sheath ...

Regular exercise is a huge help for managing schizophrenia, but barriers like medication side effects and symptoms like fatigue and lack of motivation can make this difficult.

A new study led by the University of Zurich has shown that evidence of genetic susceptibility to schizophrenia can be found in the retina. This finding could help improve the early detection of the ...

A new study has shown that evidence of genetic susceptibility to schizophrenia can be found in the retina. This finding could help improve the early detection of the disorder.

Schizophrenia is a severe and debilitating psychiatric disorder that involves psychotic symptoms such as hallucinations and delusions, accompanied with regressive behaviour. This study explores ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

We postulate that, because dopamine and serotonin both mediate schizophrenia symptoms and underlie the reinforcing effects of cocaine, the use of cocaine among individuals with schizophrenia may ...